Trilogy Capital’s Mesabi Trust MSB Stock Holding History

Trilogy Capital’s Portfolio MSB Stock Details MSB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-50	Closed	-$1K	–	409
2018 Q3	$1K	Hold	50	–	–	﹤0.01%	572
2018 Q2	$1K	Buy	+50	New	+$1.23K	﹤0.01%	533

Other funds holding MSB

BCM

Beddow Capital Management Jackson, Wyoming $265M AUM 18.36% 1-Year Est. Return

FCH

Freestone Capital Holdings Seattle, Washington $3.86B AUM 26.3% 1-Year Est. Return

ValueWorks New York $479M AUM 117.71% 1-Year Est. Return

Horizon Kinetics New York $3.06B AUM 5.37% 1-Year Est. Return

SIC

SFE Investment Counsel Los Angeles, California $742M AUM 39.38% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JMH

J.M. Hartwell New York $560M AUM 7.14% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Trilogy Capital's MSB Position: Q4 2018 in Review

Trilogy Capital sold out of Mesabi Trust (MSB) in Q4 2018, closing a stake of 50 shares — an estimated $1K sold.

Trilogy Capital first reported a position in MSB in Q2 2018 and held it in 2 quarters. The position peaked at $1K in Q3 2018. 44 funds tracked by Wall St. Rank hold MSB as of Q4 2018.

Trilogy Capital reported no remaining Mesabi Trust position as of Q4 2018 after selling out during the quarter.
Trilogy Capital sold 50 Mesabi Trust shares in Q4 2018, an estimated $1K.
Trilogy Capital first reported a position in Mesabi Trust in Q2 2018 and held it in 2 quarters.
Trilogy Capital's Mesabi Trust position peaked at $1K in Q3 2018.
44 funds tracked by Wall St. Rank held Mesabi Trust as of Q4 2018.

Based on Trilogy Capital's 13F filing for Q4 2018, filed 15 Jan 2019.